Multinight CPAP for Sleep Apnea Patients
| Status: | Terminated |
|---|---|
| Conditions: | Insomnia Sleep Studies, Pulmonary |
| Therapuetic Areas: | Psychiatry / Psychology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - 85 |
| Updated: | 12/13/2017 |
| Start Date: | May 2015 |
| End Date: | November 2016 |
Evaluation of a Multinight (MNT) CPAP Titration Algorithm in Patients With Sleep Apnea.
Obstructive sleep apnea (OSA) is a prevalent disorders characterized by intermittent
obstructions of the upper airway during sleep. Continuous Positive Airway Pressure (CPAP) has
been shown to be the most efficacious treatment for OSA. It consists of a small device that
provides positive airway pressure delivered by a mask attached to the patients nose/mouth.
obstructions of the upper airway during sleep. Continuous Positive Airway Pressure (CPAP) has
been shown to be the most efficacious treatment for OSA. It consists of a small device that
provides positive airway pressure delivered by a mask attached to the patients nose/mouth.
The primary purpose of this study is to evaluate the multinight (MNT) algorithm on patients
with Obstructive Sleep Apnea (OSA) over 45 nights while using a CPAP machine at home. The
researchers are evaluating the performance of the existing algorithm as well as capturing the
data to make enhancements.
Two main stages of this algorithm will be assessed:
i. Fast Track (FT) stage. In the FT stage the aim is to assess if the algorithm reliably and
timely reaches approximate therapeutic pressure levels.
ii. Slow Titration (ST). In the Slow Titration stage the aim is to assess if data samples
have been appropriately collected in a pressure range so that the therapeutic pressure can be
inferred according to the algorithm proposed.
with Obstructive Sleep Apnea (OSA) over 45 nights while using a CPAP machine at home. The
researchers are evaluating the performance of the existing algorithm as well as capturing the
data to make enhancements.
Two main stages of this algorithm will be assessed:
i. Fast Track (FT) stage. In the FT stage the aim is to assess if the algorithm reliably and
timely reaches approximate therapeutic pressure levels.
ii. Slow Titration (ST). In the Slow Titration stage the aim is to assess if data samples
have been appropriately collected in a pressure range so that the therapeutic pressure can be
inferred according to the algorithm proposed.
Inclusion Criteria:
- > 18 years of age
- No contradictions to Continuous Positive Airway Pressure (CPAP)
- Able to provide consent
Exclusion Criteria:
° Vulnerable subjects
We found this trial at
1
site
550 1st Ave
New York, New York 10016
New York, New York 10016
(212) 263-7300
Principal Investigator: David Rappaport, MD
New York University School of Medicine NYU School of Medicine has a proud history that...
Click here to add this to my saved trials
